8-K: Sabra Health Care REIT Reports Strong Q1 2026 Results

Sabra Health Care REIT, Inc. announced robust first quarter 2026 results, driven by strong operational performance and strategic investments, while reiterating its full-year guidance.

Summary

• Sabra Health Care REIT, Inc. reported its financial results for the first quarter ended March 31, 2026.
• Net income attributable to Sabra was $40.88 million, or $0.16 per diluted common share.
• Funds From Operations (FFO) were $0.37 per diluted share, and Normalized FFO was $0.38 per diluted share.
• Adjusted Funds From Operations (AFFO) were $0.39 per diluted share, and Normalized AFFO was also $0.39 per diluted share.
• Same-property managed senior housing Cash NOI increased by 14.4% year-over-year.
• The company completed $102.0 million in new investments during the quarter and an additional $104.1 million subsequent to quarter-end.
• Sabra has been awarded an additional $200 million in investments expected to close in Q2 2026.
• The company reiterated its full-year 2026 guidance.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive report, with strong operational performance, robust investment activity, and reiterated guidance, indicating a healthy business trajectory.

Positives

• Strong year-over-year same-store managed senior housing NOI growth of 14.4%.
• Robust investment activity, with $102.0 million invested in Q1 2026 and $104.1 million closed subsequent to quarter-end, totaling $206.1 million year-to-date with an 8.0% initial cash yield.
• Awarded an additional $200 million in investments expected to close in Q2 2026 with an estimated 8.2% initial cash yield.
• Rent coverage for all triple-net asset classes reached new highs.
• EBITDARM coverage for Skilled Nursing/Transitional Care was 2.46x, Senior Housing - Leased was 1.58x, and Behavioral Health, Specialty Hospitals and Other was 4.00x.
• Reiterated full-year 2026 guidance.
• Maintained approximately $1.2 billion in liquidity as of March 31, 2026.
• Declared a quarterly cash dividend of $0.30 per share.

Negatives

• Net Debt to Adjusted EBITDA was 5.04x as of March 31, 2026, indicating a leverage level that warrants monitoring.
• While overall revenues increased, rental and related revenues saw a slight decrease from $96.04 million in Q1 2025 to $95.05 million in Q1 2026.

Risks

• Increases in market interest rates and inflation.
• Pandemics or epidemics and their impact on tenants, borrowers, and managed communities.
• Operational risks with senior housing - managed communities.
• Increased labor costs and labor shortages.
• Competitive conditions in the industry.
• Loss of key management personnel.
• Uninsured or underinsured losses affecting properties.
• Potential impairment charges and adjustments related to asset accounting.

Future Outlook

Sabra reiterates its full-year 2026 guidance, indicating confidence in continued operational performance and investment execution. The company expects to close a significant portion of its awarded $200 million in investments during the second quarter of 2026.

Management Comments

• "Sabra is pleased to report another quarter with outstanding results."
• "Our year-over-year same-store managed senior housing NOI growth exceeded the two previous quarters as we saw NOI margin growth in our consolidated, unconsolidated and same-store portfolios."
• "Our pipeline remains robust as we closed or have been awarded over $400 million in investments to date, closing in on our investment total for all of 2025."
• "We are also executing on off-market skilled nursing deals with existing operators."
• "Our rent coverage for all triple net asset classes hit new highs, and we are reiterating our full-year guidance."
• "We appreciate the amazing work happening in the field by all the teams in the facilities. It is a mission-driven business, and their dedication exemplifies that."

Industry Context

StockSavvy.ai notes that Sabra's Q1 2026 results reflect a resilient healthcare real estate sector, particularly in senior housing and skilled nursing, driven by demographic tailwinds. The company's strategic focus on operator partnerships and disciplined investment aligns with industry trends favoring experienced, well-capitalized players.

Comparison to Industry Standards

• Sabra's Net Debt to Adjusted EBITDA of 5.04x is within the typical range for healthcare REITs, though slightly higher than some peers focused on less capital-intensive segments.
• The 14.4% year-over-year growth in same-store managed senior housing Cash NOI is a strong indicator of operational efficiency and demand, likely outperforming broader senior housing market averages.
• EBITDARM coverage ratios for triple-net assets (2.46x for SNF, 1.58x for SH-Leased, 4.00x for BH/Specialty) appear healthy and suggest operators have sufficient cash flow to meet rent obligations, a key metric for REIT stability.
• Sabra's investment yield targets (e.g., 8.3% initial cash yield on preferred equity) are competitive within the current market for healthcare real estate investments.

Stakeholder Impact

• Shareholders: Benefit from continued dividend payments ($0.30 per share declared) and potential share price appreciation driven by strong performance and growth initiatives.
• Employees: The company's success and focus on mission-driven businesses can contribute to job stability and growth opportunities within the organization and its operators' facilities.
• Operators/Tenants: Benefit from Sabra's role as a capital partner, supporting their expansion, redevelopment, and operational needs, leading to potentially improved facility performance and resident care.
• Creditors: The company's solid liquidity and reiterated guidance suggest continued ability to service debt obligations.

Next Steps

• Continue to execute on the investment pipeline, with approximately $200 million expected to close in Q2 2026.
• Monitor and manage leverage ratios, particularly Net Debt to Adjusted EBITDA.
• Continue to support operator growth and expansion through flexible capital solutions.
• Curate the portfolio to optimize diversification and future positioning.
• Fund investments using available liquidity and ATM proceeds.

Key Dates

Recommendation

The Q1 2026 results are strong and in line with expectations, with positive operational trends and continued investment activity. However, the leverage ratio (Net Debt to Adjusted EBITDA of 5.04x) warrants a cautious approach. While the company is well-positioned for growth, the current valuation and macroeconomic uncertainties suggest a 'hold' rating until further clarity on leverage reduction or sustained outperformance is observed.

Keywords

Sabra Health Care REIT, Healthcare Real Estate, Skilled Nursing Facilities, Senior Housing, REIT, Q1 2026 Earnings, FFO, AFFO